Drug intelligence / Profile preview

Acewyn-MR

Development stage
Unknown
Lead developer
Garwychem Healthcare
Modality
Small Molecules
Administration
Oral
01

Overview

Acewyn-MR is an oral combination tablet developed by Garwyn Remedies for the management of acute, painful musculoskeletal conditions and associated muscle spasms. It contains three active ingredients: the non-steroidal anti-inflammatory drug (NSAID) aceclofenac, the analgesic and antipyretic paracetamol (acetaminophen), and the centrally acting skeletal muscle relaxant chlorzoxazone. Aceclofenac and paracetamol work synergistically to alleviate pain and reduce inflammation by inhibiting cyclooxygenase (COX-1 and COX-2) enzymes, thereby suppressing prostaglandin synthesis. Chlorzoxazone acts primarily at the level of the spinal cord and subcortical areas of the brain to inhibit multisynaptic reflex arcs responsible for muscle spasms, a mechanism mediated in part by the activation of small- and intermediate-conductance calcium-activated potassium channels (KCa2.2 and KCa3.1). Together, these components provide comprehensive relief from pain, stiffness, and muscle tension.

Brand names
Acewyn-MR
Other names
Aceclofenac + paracetamol + chlorzoxazoneAceclofenac, paracetamol and chlorzoxazone
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on Acewyn-MR.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Acewyn-MR.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call